Published in Eur J Immunol on August 01, 1996
The Yin and Yang of HLA and KIR in human disease. Semin Immunol (2008) 2.72
KIR-HLA intercourse in HIV disease. Trends Microbiol (2008) 1.55
Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci U S A (1997) 1.29
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology (1999) 1.26
Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. J Immunol (2008) 1.19
Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals. Clin Exp Immunol (1999) 0.95
Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity. J Immunol (2014) 0.94
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. J Exp Med (2016) 0.83
The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function. Crit Rev Immunol (2013) 0.81
Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer. Immunology (2011) 0.79
Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells. Immunol Cell Biol (2014) 0.75
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy. Front Immunol (2017) 0.75
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80
Complete amino acid sequence of a papain-solubilized human histocompatibility antigen, HLA-B7. 2. Sequence determination and search for homologies. Biochemistry (1979) 2.71
Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism. Proc Natl Acad Sci U S A (1982) 2.36
Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates. Am J Transplant (2015) 2.08
The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect (2003) 2.07
Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis (2005) 2.05
[Survey of residents on their satisfaction after obtaining a hospital post]. Med Clin (Barc) (1997) 2.04
[Would prescription of erythropoiesis-stimulating agents in pre-dialysis change after results from TREAT study?]. Nefrologia (2009) 1.94
Morbidity of laparoscopic surgery for complicated appendicitis: an international study. Surg Endosc (2006) 1.84
Benefits of laparoscopy and the Jones technique for the nonpalpable testis. J Urol (1997) 1.81
A 38-kD Mycobacterium tuberculosis antigen associated with infection. Its isolation and serologic evaluation. Clin Exp Immunol (1989) 1.69
Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev (2000) 1.68
Human male infertility: chromosome anomalies, meiotic disorders, abnormal spermatozoa and recurrent abortion. Hum Reprod Update (2000) 1.64
Systematic approach for severe respiratory failure due to novel A (H1N1) influenza. Minerva Anestesiol (2011) 1.54
NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol (1999) 1.54
Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood (1997) 1.51
A potentiostatic study of oxygen transport through poly(2-ethoxyethyl methacrylate-co-2,3-dihydroxypropylmethacrylate) hydrogel membranes. Biomaterials (2005) 1.46
[Prognostic factors of bacteremia: prospective study]. An Med Interna (2001) 1.43
Surgical management of urinary incontinence in children with neurogenic sphincteric incompetence. J Urol (2000) 1.43
C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci (2003) 1.42
[Somatostatin receptor scintigraphy. When would a SPECT study be performed?]. Rev Esp Med Nucl (2003) 1.41
Functional, social and psychosexual adjustment after vaginal reconstruction. J Urol (1999) 1.40
[Prolonged clinical pattern of brain death in patients under barbiturate sedation: usefulness of transcranial Doppler]. Neurologia (2002) 1.39
["Stroke code". Shortening the delay in reperfusion treatment of acute ischemic stroke]. Med Clin (Barc) (1999) 1.39
Severe myoclonic epilepsy associated with mitochondrial cytopathy. Childs Nerv Syst (1995) 1.39
[Labeling of injectable drugs used in anesthesia]. Rev Esp Anestesiol Reanim (2011) 1.39
Two beta-glycanase genes are clustered in Bacillus polymyxa: molecular cloning, expression, and sequence analysis of genes encoding a xylanase and an endo-beta-(1,3)-(1,4)-glucanase. J Bacteriol (1991) 1.37
Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol (1998) 1.26
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology (1999) 1.26
Isolation of the Heterofullerene C59N as Its Dimer (C59N)2. Science (1995) 1.24
Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology (2000) 1.23
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS (2000) 1.22
Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm Res (1998) 1.21
Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting. Cancer Genet Cytogenet (2000) 1.19
Impact of aging on innate immunity. J Leukoc Biol (1998) 1.17
Immunosenescence. Immunol Today (1997) 1.16
T cells and aging (update february 1999). Front Biosci (1999) 1.15
[Conjunctival ophthalmomyiasis caused by Oestrus ovis]. Enferm Infecc Microbiol Clin (1993) 1.14
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients. Clin Exp Immunol (2005) 1.14
A nosocomial outbreak of influenza during a period without influenza epidemic activity. Eur Respir J (2003) 1.13
Primary structure of papain-solubilized human histocompatibility antigen HLA-B27. Biochemistry (1985) 1.12
HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today (1989) 1.12
Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol (2009) 1.11
Melanin production by Rhizobium meliloti GR4 is linked to nonsymbiotic plasmid pRmeGR4b: cloning, sequencing, and expression of the tyrosinase gene mepA. J Bacteriol (1993) 1.10
Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (1999) 1.08
Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes. Proc Natl Acad Sci U S A (1985) 1.07
Bladder calculi in children who perform clean intermittent catheterization. BJU Int (2000) 1.06
Meiotic abnormalities and spermatogenic parameters in severe oligoasthenozoospermia. Hum Reprod (1999) 1.06
HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens (2002) 1.05
Evolutionary breakpoints are co-localized with fragile sites and intrachromosomal telomeric sequences in primates. Cytogenet Genome Res (2005) 1.04
Further studies on anti-inflammatory activity of phycocyanin in some animal models of inflammation. Inflamm Res (1998) 1.04
Animal models for endoscopic training: do we really need them? Endoscopy (2013) 1.04
Selective decrease of CD26 expression in T cells from HIV-1-infected individuals. J Immunol (1992) 1.04
In vitro biocompatibility assessment of poly(epsilon-caprolactone) films using L929 mouse fibroblasts. Biomaterials (2004) 1.04
Complete amino acid sequence of a papain-solubilized human histocompatibility antigen HLA-B7. 1. Isolation and amino acid composition of fragments and of tryptic and chymotryptic peptides. Biochemistry (1979) 1.03
Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients. Eur J Clin Microbiol Infect Dis (2011) 1.03
Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973-1983). Int J Cardiol (1985) 1.01
Neoplasms of unknown primary site: a clinicopathological study of autopsied patients. Tumori (1993) 1.01
Manic syndrome associated with efavirenz overdose. Clin Infect Dis (2001) 1.00
Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia. J Virol (2011) 1.00
A golgi and ultrastructural study of a dominant form of Kufs' disease. J Neurol (1980) 0.99
Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes. J Immunol (1985) 0.98
Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens (2008) 0.98
Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg (2001) 0.97
Fragile sites in human and Macaca fascicularis chromosomes are breakpoints in chromosome evolution. Chromosome Res (2002) 0.97
Immune response to hepatitis B vaccine in parenteral drug abusers. Vaccine (1992) 0.97
De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C. Aliment Pharmacol Ther (2007) 0.96
Epidemiological features of rotavirus infection in Caracas, Venezuela: implications for rotavirus immunization programs. J Med Virol (1999) 0.96
T cell receptor V beta gene usage in a human alloreactive response. Shared structural features among HLA-B27-specific T cell clones. J Exp Med (1990) 0.96
Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol (1990) 0.96
HLA-B27 antigenicity: antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1 display alloantigenic specificity and discriminate among HLA-B27 subtypes. J Immunol (1986) 0.96
Prognostic indicators of chronic chagasic cardiopathy. Int J Cardiol (1991) 0.95
Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity. J Exp Med (1987) 0.95
Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases. Eur J Immunol (1993) 0.95
Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals. Clin Exp Immunol (1999) 0.95
Ureteral reimplantation in infancy: evaluation of long-term voiding function. J Urol (1999) 0.94
Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors. Eur J Immunol (1990) 0.93
Distribution of intrachromosomal telomeric sequences (ITS) on Macaca fascicularis (Primates) chromosomes and their implication for chromosome evolution. Hum Genet (2002) 0.93
A parallel solution for high resolution histological image analysis. Comput Methods Programs Biomed (2012) 0.93
Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27. J Immunol (1987) 0.93
Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones. J Immunol (1987) 0.92
Construction of a recombinant wine yeast strain expressing beta-(1,4)-endoglucanase and its use in microvinification processes. Appl Environ Microbiol (1993) 0.92
Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol (1997) 0.92
Further experience with the double onlay preputial flap for hypospadias repair. J Urol (2000) 0.92
TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int J Immunopathol Pharmacol (2010) 0.92
Lymphoid tissue viral burden and duration of viral suppression in plasma. AIDS (2001) 0.92
Variability and conformation of HLA class I antigens: a predictive approach to the spatial arrangement of polymorphic regions. Biochemistry (1984) 0.92
Long-term outcome based on the initial surgical approach to ureterocele. J Urol (1999) 0.91
The application of magnetic resonance imaging for the preoperative localization of nonpalpable testis in obese children: an alternative to laparoscopy. J Urol (2000) 0.91
Familial chondrocalcinosis. Prevalence in Northern Spain and clinical features in five pedigrees. Arthritis Rheum (1980) 0.91
Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol (1996) 0.91
Exogenous alkaline phosphatase treatment complements endogenous enzyme protection in colonic inflammation and reduces bacterial translocation in rats. Pharmacol Res (2012) 0.90
A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia. Neurosci Lett (2001) 0.90